. 1 H NMR spectrum (600 MHz) of probes 9a/9b in CDCl 3 S9 Figure S4 . 1 H, 1 H-gCOSY spectrum (600 MHz) of probes 9a/9b in CDCl 3 S10 Figure S5 . 1 H, 1 H-ROESY spectrum (600 MHz) of probes 9a/9b in CDCl 3 S11 Figure S6 . 1 H, 13 C-HSQC spectrum (600 MHz) of probes 9a/9b in CDCl 3 S12 Figure S7 . 1 H, 13 C-HMBC spectrum (600 MHz) of probes 9a/9b in CDCl 3 S13 Figure S8 . 1 H NMR spectrum (300 MHz) of A80915 (2) in CDCl 3 S14 Figure S9 . 1 H NMR spectrum (500 MHz) of intermediate 10 in CDCl 3 S14 Figure S10 . 1 H NMR spectrum (500 MHz) of probe 12 in CDCl 3 S15 Figure S11 . 1 H NMR spectrum (500 MHz) of probe 12 in C 3 DOD S15 Figure S12 . 1 H, 1 H-gCOSY spectrum (500 MHz) of probe 12 in CDCl 3 S16 Figure S13 . 1 H, 13 C-HSQC spectrum (500 MHz) of probe 12 in CDCl 3 S17 Figure S14 . 1 H, 13 C-HMBC spectrum (500 MHz) of probe 12 in CDCl 3 S18
A. General experimental methods: Chemical reagents were purchased from Acros, Fluka, Sigma-Aldrich, or TCI. Deuterated NMR solvents were purchased from Cambridge Isotope Laboratories. All reactions were conducted with rigorously dried anhydrous solvents that were obtained by passing through a solvent column composed of activated A1 alumina. N,Ndiisopropylethylamine (EtNiPr 2 ) was distilled from ninhydrin, then from KOH. All reactions conducted in oven-dried glassware sealed with septa, with stirring from a Teflon coated stir bars. Solutions were heated in a silicon oil bath. Analytical Thin Layer Chromatography (TLC) was performed on Silica Gel 60 F 254 precoated glass plates (EM Sciences). Visualization was achieved with UV light or stained with ceric ammonium molybdate. Flash chromatography was carried out Geduran Silica Gel 60 (40-63 mesh) from EM Biosciences. Yields and characterization data correspond to isolated, chromatographically and spectroscopically homogeneous materials. NMR spectra were collected on a Varian Inova 300, a Varian Inova 500, or a Bruker Biospin 600 equipped with a 1.7 mm probe. All 13 C NMR spectra were recorded with complete proton decoupling. Chemical shifts were referenced to the residual solvent for 1 H spectra, or to the 13 C signal from the deuterated solvent. Chemical shift δ values for 1 H and 13 C spectra are reported in parts per million (ppm) relative to these referenced values, and multiplicities are abbreviated as s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad. FID files were processed using MestraNova 8.0.2. (MestreLab Research). Electrospray (ESI) mass spectrometric analyses were performed using a ThermoFinnigan LCQ Deca spectrometer, and high-resolution analyses were conducted using a ThermoFinnigan MAT900XL mass spectrometer with electron impact (EI) ionization. A Thermo Scientific LTQ Orbitrap XL mass spectrometer was used for high-resolution electrospray ionization mass spectrometry analysis (HR-ESI-MS).
B. Synthesis of probe mixture 9a/9b. Construction of probe 9a/9b was accomplished through a three-step process. CNQ525.510B (1) (4.0 mg, 7.8 µmol) was dissolved in anhydrous DMF (0.4 mL). K 2 CO 3 (8.0 mg, 57.8 µmol) as added followed by tert-butyl 2-bromoacetate (5.0 µL, 33.9 µmol) dissolved in DMF (100 µL). After stirring at rt for 1h, the sample was dried with by airflow. A ~1:1 mixture of esters C15-lableled 6a and C17-labeled 6b (3.5 mg, 72%) was obtained by purification using Silica-gel HPLC eluting with a gradient of isoctane/EtOAc. A copy of a 1 H-NMR spectrum from the mixture of 6a/6b is provided in Fig. S2 . Esters 6a/6b (3.5 mg, 5.6 µmol) were dissolved in CH 2 Cl 2 (1 mL) and trifluoroacetic acid (150 µL) was added. After stirring at rt for 2h, the sample was dried by airflow. HATU (15 mg, 39.4 µmol) was added to a mixture of the crude acids 7a/7b and IAF tag 8a (8.0 mg, 27.6 mmol) dissolved in EtNiPr 2 (50 µL) and DMF (400 µL). After 12 h at rt, the sample was dried by airflow. The reaction product was dissolved in CH 3 CN and purified by reversed phase C18 HPLC to yield 3.3 mg (47%) of an ~1:1 mixture of probes 9a/9b. Repetitive HPLC or pTLC purification was able to enrich the isomeric ratios providing up to 1:2 or 2:1 mixtures of 9a/9b. Samples containing a 1:2 mixture of 9a/9b were used for the biological studies. S7 ) are provided at the end of this document. NMR characterization was complicated due to pH effects adjusting the spectral data due to the presence of amine and phenolic groups. Due to this minor peaks were observed for several of the residues.
C. Synthesis of probe mixture 12a/12b. The synthesis of probe 12 from A80915C (2) was achieved through a comparable three-step process. A80915C (2) (15.0 mg, 27.4 µmol) was dissolved in anhydrous DMF (0.4 mL). K 2 CO 3 (30.0 mg, 217.1 µmol) as added followed by tertbutyl 2-bromoacetate (15.0 µL, 101.6 µmol) dissolved in DMF (200 µL). After stirring at rt for 1h, the sample was dried by airflow. Copies of 1 H-NMR spectra from 2 and ester 10 are provided in Fig. S8 and Fig. S9 , respectively. Ester 10 (11.8 mg, 65%) was obtained by purification using Silica-gel HPLC eluting with a gradient of isoctane/EtOAc. Directly after purification, ester 10 (11.8 mg, 17.8 µmol) was dissolved in CH 2 Cl 2 (1 mL) and trifluoroacetic acid (150 µL) was added. After stirring at rt for 2h, the sample was dried by airflow. HATU (30 mg, 78.9 µmol) was added to a mixture of the crude acid 11 and IAF tag 8a (15.0 mg, 51.8 mmol) dissolved in EtNiPr 2 (50 µL) and DMF (400 µL). After 12 h at rt, the sample was dried by airflow. The reaction product was dissolved in CH 3 CN and purified by reversed phase C18 HPLC to yield 8.3 mg (53% from 10 or 34% overall from 2) of probe mixture 12. E. Apoptosis assays. Cells were incubated in six well plates with a given concentration of compound for 24 h. Cells were detached from plates using trypsin digestion and collected by centrifugation followed by washing twice with Dulbecco's Phosphate-Buffered Saline (DPBS, Life Technologies). Apoptotic analysis was performed using YO-PRO-1 iodide -propidium iodide cocktail ( A mammalian protease inhibitor cocktail (Sigma-Aldrich) was added according to the manufactures protocols. The cell suspension was then passed through 27.5 gauge needle at least five times with syringe. The crude cell lysate was filtered through a 0.45 µM membrane to remove unlysed cells and nucleic acids. The resulting material was concentrated via centrifugation on a 3 kDa spin Ultra concentrator (Amicon) until the net concentration was 1 mg/mL in total protein content using the bicinchoninic acid assay (BCA) assay (ThermoScientific Pierce) according to manufacturer's instructions. Cell lysates were prepared fresh for all IP experiments and kept on ice or at 4 °C during the entire procedure. Probe mixture 9a/9b or probe 12 was prepared as 20x stocks in DPBS containing 10% DMSO (10 mL) was added to the lysate (200 µL). After gentle shaking at 4 °C for 4 h, a 25-35 µL aliquot Affigel-10 resin containing ~4 mg/mL of anti-IAF XRI-TF35 antibody was added. The resulting slurry was incubated at 4 °C with shaking by gentle inversion using a Rotisserie Hybridization Rotator (Labquake). After 12 h, the mother liquor was removed and the resin was rapidly washed twice with ice-cold wash buffer (phosphate buffered saline (PBS), pH 7.2, 5 mM S5 EDTA, 1% NP-40, and 0.1% sodium dodecylsulfate (SDS)). The bound materials were eluted by incubation by addition of 35 µL of 100 µM 7-dimethylamino-4-coumarinacetic acid in PBS at rt for 30 min followed by centrifugation at 15,000 RPM for 5 min. The resulting solution was removed, diluted with 4x SDS-PAGE gel loading buffer (200 mM Tris-Cl pH 6.8, 400 mM DTT, 8% SDS, 0.4% bromophenol blue and 40% glycerol) and evaluated on a 4-14% gradient BisTris SDS PAGE gel (Life Technologies).
I. Trypsin Digest LC-MS/MS analyses.
The following procedures were used for the In Gel Digestion and LC-MS/MS of the bands presented in Fig. 3 from the bands identified in Fig. 2a . Protein ID analyses were conducted at UC San Diego's Biomolecular and Proteomics Mass Spectrometry Facility.
In Gel Digest:
The gel slices were cut to 1 mm × 1 mm cubes and destained three times by first washing with 100 µL of 100 mM NH 4 HCO 3 for 15 min, followed by addition of the same volume of CH 3 CN for 15 min. The supernatant wash and samples were dried in on a Speedvac (Thermo Scientific). Samples were then reduced by mixing with 200 µl of 100 mM NH 4 HCO 3 containing 10 mM DTT and incubated at 56 °C for 30 min. The liquid was removed and 200 µL of 100 mM NH 4 HCO 3 containing 55 mM iodoacetamide was added to gel pieces and incubated at rt in the dark for 20 min. After the removal of the supernatant and one wash with 100 mM NH 4 HCO 3 for 15 min, the same volume of CH 3 CN was added to dehydrate the gel pieces. The solution was then removed and samples were dried on a Speedvac (ThermoScientific). For digestion, enough solution of ice-cold trypsin (0.01 µg/µl) in 50 mM NH 4 HCO 3 was added to cover the gel pieces and set on ice for 30 min. After complete rehydration, the excess trypsin solution was removed, replaced with fresh 50 mM NH 4 HCO 3 , and left overnight at 37 °C. The peptides were extracted twice by the addition of 50 µl of 0.2% formic acid and 5% CH 3 CN and vortex mixing at rt for 30 min. The supernatant was removed and saved. A total of 50 µl of 50% CH 3 CN containing 0.2% formic acid was added to the sample, and the sample was vortexed at rt for 30 min. The supernatant was removed and combined with the supernatant from the first extraction. The combined extractions are analyzed directly by liquid chromatography (LC) in combination with tandem MS/MS mass spectroscopy using electrospray ionization.
LC-MS/MS analysis:
Trypsin-digested peptides extracted from SDS-PAGE as described above were analyzed by liquid chromatography LC-MS/MS with electrospray ionization. All nanospray ionization experiments were performed by using a QSTAR-Elite hybrid mass spectrometer (AB/MDS Sciex) interfaced to a nanoscale reversed-phase high-pressure liquid chromatograph (Tempo) using a 10 cm 180 ID glass capillary packed with 5 µm C18 Zorbax TM beads (Agilent).
The buffer compositions were as follows. Buffer A was composed of 98% H 2 O, 2% CH 3 CN, 0.2% formic acid, and 0.005% trifluoroacetic acid; Buffer B was composed of 100% CH 3 CN, 0.2% formic acid, and 0.005% trifluoroacetic acid. Peptides were eluted from the18 column into the mass spectrometer using a linear gradient of 5-60% Buffer B over 60 min at 400 µL/min. LC-MS/MS data were acquired in a data-dependent fashion by selecting the 4 most intense peaks with charge state of 2 to 4 that exceeds 20 counts, with exclusion of former target ions set to "360 seconds" and the mass tolerance for exclusion set to 100 ppm. Time-of-flight MS were acquired at m/z 400 to 1600 Da for 1 s with 12 time bins to sum. MS/MS data were acquired from m/z 50 to 2,000 Da by using "enhance all" and 24 time bins to sum, dynamic background subtract, automatic collision energy, and automatic MS/MS accumulation with the S6 fragment intensity multiplier set to 6 and maximum accumulation set to 2 s before returning to the survey scan. Peptide identifications were made using paragon algorithm executed in Protein Pilot 2.0 (Life Technologies).
J. Western blot analyses. Samples of the immunopreciptiated fractions obtained from the immunoprecipitation assay were evaluated for their protein content using bicinchoninic acid assay (BCA) assay 23235 (ThermoScientific Pierce) according to manufacturer's instructions. Protein (20 µg) was loaded per well on a 10% tris PAG polyacrylamide gel. Gels were wet transferred onto a polyvinylidene fluoride (PVDF) membrane and blocked in 5% dry milk. After blocking, the membrane was incubated overnight at 4º C with primary antibody mouse anti-GRP94 (G4545, Sigma Aldrich) at 1:500 in Tris-buffered saline containing 0.01% tween and 5% dry milk (TBST). The membrane was washed four times with an equal volume of TBST. Blot was incubated for 1 h in TBST with anti-mouse HRP antibody (1:5000). Detection was performed using Super Signal West Pico Chemiluminescent Substrate 34078 (ThermoScientific Pierce) according to manufacturer's instructions.
K. Cloning and expression of hGrp94. hGrp94 cloned from a cDNA library (OriGene) into pET28b vector containing 819 amino acids (22-803 aa) and an N-terminal 10 tag. The resulting hGrp94a5 vector was transfected into Escherichia coli One Shot BL-21 Star cells (Life Technologies). Protein (was obtained from bacterial pelleted from a 6 L production using standard IPTG induction procedures. Cells were lysed by French Press and the recombinant hGrp94 was purified via sequential Ni-NTA agarose resin, followed by anion exchange and gel filtration as described for the purification of canine Grp94 by Gewirth. HPLC analyses were conducted in triplicate for each and the average was reported all studies within 3% deviation. Data were reported using the UV absorbance detected at 380 nM as given by peak area. Concentrations were determined by comparison with a series of standards of 1 and 2 with concentrations of 100 nM, 500 nM, 1 µM, 2 µM, 5 µM, 10 µM, 15 µM, 25 µM and 50 µM. Each experiment was conducted in triplicate and error bars were reported depicting deviations from these runs. For each experiment, an average of three HPLC readings was collected. Data was processed and plotted using Prism 6 (Graphpad). 
